Twice-daily application of HIV microbicides alters the vaginal microbiota

mBio

Volumn 3, Issue 6, 2012, Pages

  Ravel, Jacques ^a   Gajer, Pawel ^a   Fu, Li ^a   Mauck, Christine K ^b   Koenig, Sara S K ^a   Sakamoto, Joyce ^a,f   Motsinger Reif, Alison A ^c   Doncel, Gustavo F ^b   Zeichner, Steven L ^d,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE SULFATE; GENOMIC DNA; NONOXINOL 9; PLACEBO; RNA 16S;

ADULT; ANAEROBIC BACTERIUM; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DRUG EFFECT; DRUG TREATMENT FAILURE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GARDNERELLA VAGINALIS; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; MICROBIAL COMMUNITY; MONTE CARLO METHOD; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROBABILITY; PYROSEQUENCING; RISK FACTOR; RNA GENE; SPECIES COMPOSITION; STATISTICAL MODEL; STREPTOCOCCUS; VAGINA FLORA; VIRUS TRANSMISSION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS CRISPATUS;

EID: 84872146138     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00370-12     Document Type: Article

References (33)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2010. UNAIDS Report on the global AIDS epidemic 2010. UNAIDS, Geneva, Switzerland.
2. Abdool Karim Q, et al. 2010. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168-1174.
3. Rohan LC, et al. 2010. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One 5:e9310.
4. Halpern V, et al. 2008. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS One 3:e3784.
5. Van Damme L, et al. 2008. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N. Engl. J. Med. 359:463-472.
6. Van Damme L, et al. 2002. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial. Lancet 360:971-977.
7. Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB, Doncel GF. 2011. Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. mBio 2:e00168-11.
8. Richardson BA, et al. 1998. Use of nonoxynol-9 and changes in vaginal lactobacilli. J. Infect. Dis. 178:441-445.
9. Rosenstein IJ, et al. 1998. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J. Infect. Dis. 177:1386-1390.
10. Bakken LR. 1985. Separation and purification of bacteria from soil. Appl. Environ. Microbiol. 49:1482-1487.
11. Staley JT, Konopka A. 1985. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol. 39:321-346.
12. Ravel J, et al. 2011. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl 1):4680-4687.
13. Gajer P, et al. 2012. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4:132ra152.
14. Fredricks DN, Fiedler TL, Marrazzo JM. 2005. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl J.Med.353:1899-1911.
15. Srinivasan S, Fredricks DN. 2008. The human vaginal bacterial biota and bacterial vaginosis. Interdiscip. Perspect. Infect. Dis. 2008:750479.
16. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29:297-301.
17. Martin HL, et al. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180:1863-1868.
18. Taha TE, et al. 1998. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12:1699-1706.
19. Schwartz JL, et al. 2006. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception 74:133-140.
20. Trifonova RT, Doncel GF, Fichorova RN. 2009. Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses. Antimicrob. Agents Chemother. 53:1490-1500.
21. Herbst-Kralovetz MM, et al. 2008. Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am. J. Reprod. Immunol. 59:212-224.
22. Joseph T, et al. 2012. Induction of cyclooxygenase (COX)-2 in human vaginal epithelial cells in response to TLR ligands and TNF-a. Am. J. Reprod. Immunol. 67:482-490.
23. McKenna P, et al. 2008. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 4:e20.
24. Carlton JM, et al. 2007. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315:207-212.
25. Lin J. 1991. Divergence measures based on the Shannon entropy. IEEE Trans. Info. Theory 37:145-151.
26. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. 2003. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. 37:319-325.
27. Peters SE, et al, 2000. Behaviors associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin. Pediatr. (Phila) 39:173-177.
28. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. 2003. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36:663-668.
29. Plummer M. 2010. JAGS, version 2.2.0. User manual. http://www-fis.iarc.fr/martyn/software/jags.
30. Plummer M. 2011. Rjags: Bayesian graphical models using MCMC. R. Package Version 2.1.-0 -2.
31. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
32. Gelman A, Rubin DB. 1992. Inference from iterative simulation using multiple sequences. Stat. Sci. 7:457-511.
33. Plummer M, Best N, Cowels K, Vines K. 2008. Coda: output analysis and diagnostics for MCMC. R. Package Version 0.-13-15.